Evaluation of the Use of Anti-Diabetic Drugs in Outpatient Type 2 Diabetes Mellitus Patients at Lasinrang Regional General Hospital, Pinrang Regency in 2023

Rizqi Nur Azizah; Alfina Damayanti; Dewi Yuliana

doi:10.70392/jpns.v1i3.94101

Authors

Rizqi Nur Azizah Moslem University of Indonesia Author
Alfina Damayanti Faculty of Pharmacy Universitas Muslim Indonesia Author
Dewi Yuliana Faculty of Pharmacy Universitas Muslim Indonesia Author

DOI:

https://doi.org/10.70392/jpns.v1i3.94101

Keywords:

Diabetes mellitus , Outpatient, Evaluation drug used

Abstract

Diabetes Mellitus (DM), including a disease in the form of metabolic disorders characterized by impaired insulin secretion, impaired insulin production and insulin sensitivity, causing an increase in blood sugar levels (hyperglycemia). This study aims to determine the use of antidiabetic drugs which include the right drug, the right dose, the right indication and the right frequency of administration in outpatient type II diabetes mellitus patients at Lasinrang Regional General Hospital, Pinrang District in 2023. This study is a non-experimental research with a descriptive design retrospectively. The sample in this study is all outpatients with a diagnosis of type II diabetes mellitus at the Lasinrang Regional General Hospital, Pinrang District in 2023. The sampling technique used is purposive sampling. The sample of this study is medical record data of patients with type II diabetes mellitus in 2023, which is adjusted to the inclusion criteria. The results of the study showed that of 87 samples consisting of 55 women and 32 men, all of which met the inclusion and exclusion criteria, and showed that the prevalence of age was more susceptible to be affected at the age of 46-55 years as many as 40 patients (45.98%). In the analysis of the accuracy of drug use, outpatient type II diabetes mellitus patients at the Lasinrang Regional General Hospital, Pinrang regency in 2023 have an indication accuracy of 100%, 100% drug accuracy, 100% dose accuracy, and 100% accuracy frequency of drug administration.

References

Husen, F., Hernayanti, H., Ekowati, N., Sukmawati, D., Ratnaningtyas, N.I. Antidiabetic effects and antioxidant properties of slack ink cap medicinal mushroom, Coprinus comatus (Agaricomycetes) in streptozotocin-induced hyperglycemic rats. In-ternational Journal of Medicinal Fungi 2021, 23(10), 9-21.

Ministry of Health, R.I. Indonesia's health profile. Jakarta: Ministry of Health, Republic of Indonesia, 2014.

PERKENI. Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Pb Perkeni. 2021, 1-46.

Basic Health Research (Riskesdas). Ministry of Health Research and Development Agency of the Republic of Indonesia. 2018

WHO. Global Report on Diabetes. [Internet]. 2024 [cited 2024 November 27] Available from: https://www.who.int/publications/i/item/9789241565257

American Diabetes Association. Pharmacologic approaches to glycemic treatment: Standards of medical care in diabetes 2021. Diabetes Care 2021, (44) 111–124.

Anggraini, D., Hidayat, W. Correlation of Blood Sugar Levels with the Angkel Bracial Index (Abi) Value of Diabetes Mellitus Patients in the Inpatient Room of Ibnu Sina Bukittinggi Islamic Hospital in 2013. Afiyah 2014, 1(1), 1-8.

Jia, Y., Lao, Y., Leung, S. Glycemic Control Efficacy of Oral Antidiabetic Drugs in Treating Type 2 Diabetes: protocol for network meta-analysis. BMJ Open 2015, 4(11), 1-4.

Kardela, W., Abdillah, R., Handicka, G. Rationality of Drug Use for Diabetes Mellitus Type 2 Complications of Nephropathy at Central General Hospital Dr. M. Djamil Padang. Higea Pharmacy Journal 2019, 11(2), 195-200.

Sihombing, A.G.G. Rationality of diabetes mellitus type II treatment. Journal of Medika Hutama 2022, 3(2), 2175-2179.

Ramdini, D.A., Wahidah, L.K., Atika, D. Evaluation of the rationality of the use of type II diabetes mellitus drugs in outpatients at Pasir Sakti Health Center in 2019, Jurnal Farmasi Lampung 2020, 9(1), 69-76.

Yuliana, D., Widowati, F.D., Fawwaz, M. Pharmacoeconomic analysis of chemotherapy regimen of breast cancer patients at Hasanuddin University Hospital, Makassar. Pharmaceutical Media 2024, 20(1), 71-83.

Anggitasari, W., Pebriarti, I.W., Mayasari, S. Evaluation of the Rationality of Type 2 Diabetes Mellitus Treatment in Outpatients at One of the Jember Regency Hospitals. PHARMACON 2024, 13(1), 378-383.

Kurniawati, T., Lestari, D., Rahayu, A.P., Syaputri, F.N., Tugon, T.D.A. Evaluation of the profile of antidiabetic drug use among outpatients with type 2 diabetes mellitus in one of the hospitals in Bogor Regency. Journal of Science, Technology and En-trepreneurship 2021, 3(1), 1-4.

American Diabetes Association, Standards of Medical Care in Diabetes. USA: Diabetes Care, 2016.

Sari, P.A., Primadiamanti, A., Angin, M.P. Evaluation of the rationality of the use of antidiabetic drugs in patients with type 2 diabetes mellitus with hypertension complications at Pertamina Bintang Amin Hospital, Bandar Lampung. Journal of Medika Malahayati 2023, 7(1), 498.

Azizah, R. N., Hudayah, A. Identification of drug use in elderly type II diabetes mellitus patients with Beer's Criteria in the Inpatient installation of Ibnu Sina Hospital Makassar Period 2012. As-Syifaa Pharmacy Journal 2016, 8(1), 82-94.

Rojas, L.B.A. Gomes, M.B. Metformin: An old but still the best treatment for type 2 diabetes. Diabetology and Metabolic Syndrome 2013, 5, 1-5.

Hidayat, A. N., & Siwi, K. Evaluation of rationality of oral antidiabetes medications on the effectiveness of therapy for diabetes melites tip ii patients at dr. moewardi surakarta Hospital. Jambura Journal of Health Sciences and Health Research 2023, 5(3), 815-824.

Ministry of Health, R. I. Module on Rational Use of Medicines. Pharmaceutical Services Development, Jakarta 2011.